Context Recent studies of inhaled corticosteroid (ICS) therapy for managing stable chronic
obstructive pulmonary disease (COPD) have yielded conflicting results regarding survival …

PURPOSE: Although inhaled corticosteroids are commonly used to treat patients with
chronic obstructive pulmonary disease (COPD), their effect on clinical outcomes such as …

Background The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary
disease (COPD) has been the subject of much controversy. Major international guidelines …

Background: Clinical studies suggest that inhaled corticosteroids reduce exacerbations and
improve health status in chronic obstructive pulmonary disease (COPD). However, their …

Recent data suggest that inhaled corticosteroids reduce the number of clinical
exacerbations in chronic obstructive pulmonary disease (COPD). It remains unknown …

Rationale: Treatment with inhaled corticosteroids (ICS) for those with chronic obstructive
pulmonary disease (COPD) has been shown to be associated with an increased incidence …

Observational studies of inhaled corticosteroids in chronic obstructive pulmonary disease
(COPD) have shown improved survival whereas randomized trials have not. It has been …

Background The use of inhaled corticosteroids in patients with chronic obstructive
pulmonary disease (COPD) has been associated with an increased risk of pneumonia in …

Background Recent studies have suggested a possible association between pneumonia
and the use of inhaled corticosteroids. We aimed to ascertain the risk of pneumonia with …

Current guidelines for the management of chronic obstructive pulmonary disease (COPD)
recommend limiting the use of inhaled corticosteroids (ICS) to patients with more severe …